Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome
- PMID: 24420723
- DOI: 10.1007/s10067-013-2476-z
Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome
Abstract
The aim of this study is to investigate the correlation between clinical parameter, Th17, and degree of lymphocytes infiltrating in labial salivary gland in primary Sjögren's syndrome (pSS). Minor labial gland biopsies from a cohort of 103 patients fulfilling the American-European consensus classification criteria for pSS were examined and grouped into G1 to G3 according to infiltration degree of lymphocytes in labial salivary glands and formation of germinal center. IL-17 level and Th17 proportion of peripheral blood samples in 54 patients with pSS were analyzed simultaneously. Among the 103 labial salivary glands samples, there were 10.5 % of G1, 68.4 % of G2, and 21.1 % of G3, respectively. Some clinical parameters were markedly associated with the degree of inflammatory cells infiltration in labial glands, including white blood cell counts, lymphocytes, liver enzymes, and pulmonary function diffusion rates. The average optical density of IL-17 correlated with the severity of lymphocytic infiltration in the labial glands, while the proportion of Th17 cells in the peripheral blood mononuclear cells showed no significant relationship to the degree of lymphocytic infiltration in the labial glands from the SS patients. IL-17A mRNA levels in peripheral blood mononuclear cells from pSS patients before immunosuppressant treatment were significantly higher than that in patients after immunosuppressant treatment. The degree of inflammatory cells infiltration in labial glands was related to some clinical manifestations in pSS. IL-17 may play a role in the pathogenesis of lymphocytic infiltration in the labial glands. Immunosuppressive treatment might affect Th17 cells.
Comment in
-
IL-17, a potential therapeutic target for Sjögren's syndrome?Clin Rheumatol. 2015 Sep;34(9):1657-8. doi: 10.1007/s10067-014-2621-3. Epub 2014 Apr 22. Clin Rheumatol. 2015. PMID: 24752349 No abstract available.
Similar articles
-
IL-17, a potential therapeutic target for Sjögren's syndrome?Clin Rheumatol. 2015 Sep;34(9):1657-8. doi: 10.1007/s10067-014-2621-3. Epub 2014 Apr 22. Clin Rheumatol. 2015. PMID: 24752349 No abstract available.
-
Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.J Pathol. 2004 Apr;202(4):496-502. doi: 10.1002/path.1533. J Pathol. 2004. PMID: 15095277
-
Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.J Cell Mol Med. 2016 Apr;20(4):613-22. doi: 10.1111/jcmm.12793. Epub 2016 Feb 1. J Cell Mol Med. 2016. PMID: 26828975 Free PMC article.
-
Labial salivary gland biopsy in Sjögren's syndrome.Neth J Med. 1992 Apr;40(3-4):148-57. Neth J Med. 1992. PMID: 1603205 Review.
-
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.Ann Rheum Dis. 2017 Jul;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448. Epub 2016 Dec 13. Ann Rheum Dis. 2017. PMID: 27965259 Free PMC article.
Cited by
-
Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment.Front Immunol. 2022 Oct 28;13:995895. doi: 10.3389/fimmu.2022.995895. eCollection 2022. Front Immunol. 2022. PMID: 36389806 Free PMC article. Review.
-
Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.Int J Mol Sci. 2020 Dec 1;21(23):9172. doi: 10.3390/ijms21239172. Int J Mol Sci. 2020. PMID: 33271951 Free PMC article. Review.
-
T Helper 17 Cells in Primary Sjögren's Syndrome.J Clin Med. 2017 Jul 5;6(7):65. doi: 10.3390/jcm6070065. J Clin Med. 2017. PMID: 28678161 Free PMC article. Review.
-
Th17 cells in autoimmune diseases.Front Med. 2015 Mar;9(1):10-9. doi: 10.1007/s11684-015-0388-9. Epub 2015 Feb 4. Front Med. 2015. PMID: 25652649 Review.
-
Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjögren's syndrome: a comparative study.Rheumatol Int. 2022 Aug;42(8):1411-1421. doi: 10.1007/s00296-021-04949-6. Epub 2021 Jul 20. Rheumatol Int. 2022. PMID: 34283264
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical